In conclusion, ARHGAP9 was decreased in HCC, and aberrant expression of ARHGAP9 can affect migration and invasion of HCC cells, probably through regulating FOXJ2 and its target gene CDH1. This evidence concerns the gene FOXJ2 and hepatocellular carcinoma.